Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>The Chemours Company’s third-quarter 2024 results present a mixed picture, reflecting both commendable strategic implementation and ongoing market challenges.</li><li>The quarter witnessed a 1% increase in consolidated net sales to approximately $1.5 billion, driven by a 5% rise in volume, though partially offset by a 3% decline in pricing and a slight currency headwind.</li><li>This reflects the company's effective operational execution and successful navigation through previous disruptions, evidenced by year-over-year volume growth across all business segments.</li></ul>

The Chemours Company’s third-quarter 2024 results present a mixed picture, reflecting both commendable strategic implementation and ongoing market challenges.The quarter witnessed a 1% increase in consolidated net sales to approximately $1.5 billion, driven by a 5% rise in volume, though partially offset by a 3% decline in pricing and a slight currency headwind.This reflects the company's effective operational execution and successful navigation through previous disruptions, evidenced by year-over-year volume growth across all business segments.

The Chemours Company: Its’ Strategic Portfolio Overhaul Maximizing Returns in High-Growth Markets! - Major Drivers

<ul><li>The Chemours Company faced various challenges in the second quarter of 2024, yet demonstrated resilience and adaptability in managing these issues.</li><li>Key points from the earnings call include the impact of a severe drought on their titanium dioxide production at Altamira, Mexico, which led to unplanned downtime and an $8 million cost for the quarter.</li><li>Despite this, Chemours was proactive in addressing the immediate needs of affected employees and the community while optimizing production to meet customer demands, achieving a 16% increase in volumes compared to the first quarter.</li></ul>

The Chemours Company faced various challenges in the second quarter of 2024, yet demonstrated resilience and adaptability in managing these issues.Key points from the earnings call include the impact of a severe drought on their titanium dioxide production at Altamira, Mexico, which led to unplanned downtime and an $8 million cost for the quarter.Despite this, Chemours was proactive in addressing the immediate needs of affected employees and the community while optimizing production to meet customer demands, achieving a 16% increase in volumes compared to the first quarter.

The Chemours Company: Expansion of Fluoropolymer Applications & Dealing With Fluctuating Demand! - Major Drivers

<ul><li>The Chemours Company's fourth quarter and year-end 2023 earnings revealed a mixed bag of results, reflecting both the challenges and potential for the company.</li><li>On one side, the company faced various hurdles including softness in economically sensitive end markets, higher input costs, and extended outage at one of the manufacturing sites.</li><li>Despite these headwinds, Chemours still demonstrated strong areas of growth and several promising developments, emphasizing the resilience and potential the company has.</li></ul>

The Chemours Company's fourth quarter and year-end 2023 earnings revealed a mixed bag of results, reflecting both the challenges and potential for the company.On one side, the company faced various hurdles including softness in economically sensitive end markets, higher input costs, and extended outage at one of the manufacturing sites.Despite these headwinds, Chemours still demonstrated strong areas of growth and several promising developments, emphasizing the resilience and potential the company has.

The Chemours Company: What Are The Potential Growth Opportunities Ahead? - Major Drivers

The Chemours Company: Initiation Of Coverage - A Deep Dive Analysis Of Its Seemingly Robust Financial Situation - Major Drivers

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<ul>
<li>Last week we noted the S&amp;P 500 was testing support at 3800-3860 within its downtrend channel and that we were on watch for a potential bear market rally/oversold bounce.</li>
<li>This has officially begun following the break above 4030 on the S&amp;P 500, which was confirmed by bullish reversals on the Russell 2000, Nasdaq 100, DAX, Hang Seng, MCHI, KWEB.</li>
<li>As long as 3858 holds, it is possible the S&amp;P 500 breaks above the longer-term downtrend near the 200-day MA, which would mean the start of a new bull market.</li>
</ul>


Last week we noted the S&amp;P 500 was testing support at 3800-3860 within its downtrend channel and that we were on watch for a potential bear market rally/oversold bounce.
This has officially begun following the break above 4030 on the S&amp;P 500, which was confirmed by bullish reversals on the Russell 2000, Nasdaq 100, DAX, Hang Seng, MCHI, KWEB.
As long as 3858 holds, it is possible the S&amp;P 500 breaks above the longer-term downtrend near the 200-day MA, which would mean the start of a new bull market.


Bear Market Rally With Potential for More; Buy Ideas in Shipping, Land Drilling, Refining, Chemicals

United States

The Chemours Company manufactures and distributes performance chemicals. The Company produces titanium dioxide, refrigerants and industrial fluoropolymer resins, and industrial and specialty chemicals for gold producing, oil refining, agriculture, and other industries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Chemours Co/The (CC US)

The Chemours Company: Its’ Strategic Portfolio Overhaul Maximizing Returns in High-Growth Markets! - Major Drivers

The Chemours Company’s third-quarter 2024 results present a mixed picture, reflecting both commendable strategic implementation and ongoing market...

Baptista Research

The Chemours Company: Expansion of Fluoropolymer Applications & Dealing With Fluctuating Demand! - Major Drivers

The Chemours Company faced various challenges in the second quarter of 2024, yet demonstrated resilience and adaptability in managing these...

Baptista Research

The Chemours Company: What Are The Potential Growth Opportunities Ahead? - Major Drivers

The Chemours Company's fourth quarter and year-end 2023 earnings revealed a mixed bag of results, reflecting both the challenges and potential for...

Baptista Research

The Chemours Company: Initiation Of Coverage - A Deep Dive Analysis Of Its Seemingly Robust Financial Situation - Major Drivers

The Chemours Company's fourth quarter and year-end 2023 earnings revealed a mixed bag of results, reflecting both the challenges and potential for...

Baptista Research

Bear Market Rally With Potential for More; Buy Ideas in Shipping, Land Drilling, Refining, Chemicals

With the $SPX reversing topside the 1-month downtrend (at 4030), the bear market rally is underway with the potential for more. Resistance levels:...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)